Inactive Instrument

Bakhu Holdings, Corp. Stock Other OTC

Equities

BKUH

US0575862083

Healthcare Facilities & Services

Sales 2022 - Sales 2023 - Capitalization 298M
Net income 2022 -20M Net income 2023 -10M EV / Sales 2022 -
Net Debt 2022 6.36M Net Debt 2023 6.74M EV / Sales 2023 -
P/E ratio 2022
-15.8 x
P/E ratio 2023
-28.9 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 34.7%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Director of Finance/CFO 51 21-12-05
Chief Tech/Sci/R&D Officer 55 12-08-02
Director/Board Member 29 12-08-02
Members of the board TitleAgeSince
Director of Finance/CFO 51 21-12-05
Chairman 63 Feb. 26
Chief Tech/Sci/R&D Officer 55 12-08-02
More insiders
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
More about the company